Selective inhibition of receptor activator of NF-κB ligand (RANKL) in hematopoietic cells improves outcome after experimental myocardial infarction.
about
Selective inhibition of receptor activator of NF-κB ligand (RANKL) in hematopoietic cells improves outcome after experimental myocardial infarction.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Selective inhibition of recept ...... imental myocardial infarction.
@en
Selective inhibition of receptor activator of NF-κB ligand
@nl
type
label
Selective inhibition of recept ...... imental myocardial infarction.
@en
Selective inhibition of receptor activator of NF-κB ligand
@nl
prefLabel
Selective inhibition of recept ...... imental myocardial infarction.
@en
Selective inhibition of receptor activator of NF-κB ligand
@nl
P2093
P2860
P1476
Selective inhibition of recept ...... rimental myocardial infarction
@en
P2093
Claudia Bergow
Kristopher Ford
Lorenz C Hofbauer
Nejla Latic
Olena Andrukhova
Paul J Kostenuik
Soleman Sasgary
Stephan Handschuh
Svetlana Slavic
Ursula Reichart
P2860
P2888
P304
P356
10.1007/S00109-018-1641-X
P577
2018-05-08T00:00:00Z
P6179
1103854810